| Detected | Trial | Change |
|---|---|---|
| 2026-06-05 | NCT03919240 CAR-T Cell Therapy Targeting to CD19 for R/R ALL |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-06-02 | NCT04745221 Efficacy and Safety of Auto-FMT in Preventing aGVHD |
date change Primary completion pushed: 2026-03-01 -> 2027-03-01 |
| 2026-06-02 | NCT04745221 Efficacy and Safety of Auto-FMT in Preventing aGVHD |
date change Completion pushed: 2026-03-01 -> 2027-03-01 |
| 2026-05-30 | NCT06985498 Immunotherapy Combined With Auto-HSCT and CD22/CD19 CAR-T Sandwich Strategy for B-ALL |
overall status: "Not Yet Recruiting" → "Suspended" |
| 2026-05-30 | NCT06985498 Immunotherapy Combined With Auto-HSCT and CD22/CD19 CAR-T Sandwich Strategy for B-ALL |
critical why stopped: null → "According to the new regulations of China, newly launched clinical trials involved CAR-T cells must be apporved first by China National Center for Biotechology Development." |
| 2026-05-29 | NCT07511426 U96-CAR-T-Cells For R/R B-ALL |
overall status: "Recruiting" → "Not Yet Recruiting" |
| 2026-05-15 | NCT07583888 VABu Conditioning in Elderly AML HSCT |
overall status: "Enrolling By Invitation" → "Recruiting" |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-09 | NCT07635485 VA Induction and Bridging Transplantation for Hypoplastic/Secondary AML | Not Yet Recruiting | |
| 2026-06-09 | NCT07635511 Acalabrutinib Maleate and Bortezomib for Patients With HLA Antibodies | Phase 3 | Not Yet Recruiting |
| 2026-06-03 | NCT07622849 FMT in Transplant-related Gastrointestinal Mucositis | Enrolling by Invitation | |
| 2026-06-02 | NCT07621406 Efficacy and Safety of Sequential Autologous Hematopoietic Stem Cell Transplantation… | Phase 2 | Active, Not Recruiting |
| 2026-05-28 | NCT07612319 Romiplostim for Oral TPO-RA Resistant ITP | Recruiting | |
| 2026-05-27 | NCT07609446 Pomalidomide Plus Anti-CD20 Antibody and Prednisone in Frontline Indolent B-Cell Lymphoma | Not Yet Recruiting | |
| 2026-05-20 | NCT07599423 A Study of Glofitamab Plus GemOx Compared With Standard of Care in Patients With… | Phase 2 | Not Yet Recruiting |
| 2026-05-15 | NCT07589790 Effect of VR-MBCT in Chronic Nonspecific Low Back Pain | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07463651 | MRD-guided Maintenance Post-HCT: Gilteritini vs Sorafenib | Acute Myeloid Leukemia (AML) | Recruiting |
| NCT07486479 | Venetoclax, Azacitidine, and Mitoxantrone Hydrochloride Liposome Versus Idarubicin and… | Acute Myeloid Leukemia (AML) | Not Yet Recruiting |
| NCT07635511 | Acalabrutinib Maleate and Bortezomib for Patients With HLA Antibodies | Hematological Malignancies | Not Yet Recruiting |
| Phase 2/3 | |||
| NCT07583888 | VABu Conditioning in Elderly AML HSCT | Allogeneic Hematopoietic Stem Cell Transplantation Recipient | Recruiting |
| Phase 2 | |||
| NCT05657639 | CAV Regimen for R/R AML | Acute Myeloid Leukemia | Recruiting |
| NCT07372352 | Zeprumetostat, Azacitidine Combined With Lipo-MIT in R/R PTCL | Peripheral T Cells Lymphoma (PTCL) | Recruiting |
| NCT07372365 | Orelabrutinib as Consolidation and Maintenance Therapy in Treatment-Naïve MZL. | Marginal Zone Lymphoma (MZL) | Recruiting |
| NCT05376111 | Study of Venetoclax Combined With Azacitidine Regimen in Newly Diagnosed T-ALL Patients | T-cell Acute Lymphoblastic Leukemia | Recruiting |
| NCT06220162 | VAC Regimen for AML Patients Who Failed to Response to VA Regimen | Acute Myeloid Leukemia | Recruiting |
| NCT06379360 | Maintenance Therapy of Hypomethylating Agent (HMA) in Favorable Risk Acute Myeloid… | Acute Myeloid Leukemia | Recruiting |
| NCT06985485 | Full-Course Immunotherapy Consolidation for Unfit or Fit B-ALL Who Decline Chemotherapy | Acute Lymphoblastic Leukemia | Recruiting |
| NCT07499271 | Genetic Subtype-matched Targeted Therapy for the Treatment of Newly Diagnosed DLBCL With… | Diffuse Large B-Cell Lymphoma (DLBCL) | Recruiting |
| NCT07400328 | Amimestrocel Injection for Preventing Severe Oral Mucositis in HSCT Patients | Oral Mucositis | Recruiting |
| NCT07400341 | Romiplostim Versus rhTPO for Platelet Engraftment After Transplant in MDS and AA | MDS (Myelodysplastic Syndrome) | Recruiting |
| NCT06816134 | Study on the Efficacy and Safety of the TmBU Conditioning Regimen in High-risk or… | Acute Myeloid Leukemia | Recruiting |
| NCT05182957 | Clinical Study on Anti-PD-1 Plus Lenalidomide and Azacitidine in Relapsed/Refractory… | Relapsed/Refractory Peripheral T-cell Lymphoma | Recruiting |
| NCT07564453 | Full-course Immunotherapy Combined With Chemotherapy in Newly Diagnosed B-cell Acute… | B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative | Recruiting |
| NCT07425782 | Venetoclax Combined With Azacitidine for Consolidation Therapy in AML | Acute Myeloid Leukemia | Not Yet Recruiting |
| NCT07454018 | Iparomlimab/Tuvonralimab + Standard Chemotherapy and Olaparib in Platinum-Sensitive… | Recurrent Ovarian Cancer | Not Yet Recruiting |
| NCT05029141 | New Double Epigenetic Regimen in the Treatment of Relapsed or Refractory Acute Myeloid… | Acute Myeloid Leukemia | Active, Not Recruiting |
| NCT07562568 | SHR2554/AZA + Overlapped TBF for High-risk/Relapsed Leukemia/MDS | Acute Myeloid Leukemia | Not Yet Recruiting |
| NCT07573670 | A Phase 2 Study of Bcl-2 Inhibitor Combined With Azacitidine for Newly Diagnosed Mixed… | Newly Diagnosed Mixed Phenotype Acute Leukemia | Not Yet Recruiting |
| NCT07599423 | A Study of Glofitamab Plus GemOx Compared With Standard of Care in Patients With… | Large B-cell Lymphoma | Not Yet Recruiting |
| NCT05470777 | CD22/CD19 CAR-T and Auto-HSCT Sandwich Strategy as Consolidation Therapy for B-ALL | B-cell Acute Lymphoblastic Leukemia | Active, Not Recruiting |
| NCT07621406 | Efficacy and Safety of Sequential Autologous Hematopoietic Stem Cell Transplantation… | Relapsed/Refractory Diffuse Large B Cell Lymphoma | Active, Not Recruiting |